Associations between mRNA COVID-19 vaccination and urticaria: a nationwide registry-based cohort study in Denmark
Scandinavian Journal of Public Health · 2025
DOI: 10.1177/14034948251333901 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Scandinavian Journal of Public Health, 2025. Verfasst von Elena Dudukina und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Data Analytics Centre, Danish Medicines Agency, Copenhagen S, Denmark. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Urticaria, mRNA Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objectives
To investigate the association between mRNA COVID-19 vaccination and the risk of urticaria. Study design: Nationwide observational cohort study.
Setting
Healthcare registers in Denmark.
Participants
The vaccinated cohort included Danish residents aged ⩾5 years who received at least one dose of Comirnaty (Pfizer–BioNTech, BNT) or Spikevax (Moderna, MOD) in December 2020 to July 2023; the pre-pandemic (2017-19) general population aged ⩾5 years formed the comparator cohort.
Methods
Urticaria-free participants were followed from the vaccination date until the earliest of the incident chronic or other types of urticaria diagnosis, COVID-19 infection, end of the 90-day outcome risk window, death, emigration, or October 2023. The expected number of urticaria events was computed using indirect standardisation of the pre-pandemic urticaria incidence rates. Standardised incidence ratios (SIRs) with corresponding 95% confidence intervals (CIs) were calculated overall and across sex, age and vaccine sequence-specific strata.
Results
We ascertained 4,700,301 vaccinated and 5,480,146 pre-pandemic comparators. Following all vaccine product sequences, SIRs (95% CI) were 0.83 (0.71-0.96) for chronic urticaria and 1.14 (95% CI 1.03–1.25) for other types of urticaria. Among MOD schedule adherers, the risk was three to fourfold increased for chronic (SIR 3.00, 95% CI 2.27–3.88) and other types of urticaria (SIR 3.65, 95% CI 3.06–4.31). Sensitivity analyses of dose specific effects confirmed a fourfold increased risk after MOD vaccine sequence but not BNT.
Conclusions
Following the most recent mRNA vaccination dose, MOD vaccine schedule adherers had a higher than expected incidence of chronic and other types of urticaria. We found no association between BNT vaccination schedule and increased risk of urticaria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Data Analytics Centre, Danish Medicines Agency, Copenhagen S, Denmark.
- Pharmacovigilance Division Danish Medicines Agency, Copenhagen S, Denmark.
ORCID-Profile: Elvira V Brâuner
Zitieren
APA
Dudukina, E., Brâuner, E. V., Christiansen, C. B., Mogensen, S. H., Hervig, M. E., Ulsø, S., & Larsen, M. Z. (2025). Associations between mRNA COVID-19 vaccination and urticaria: a nationwide registry-based cohort study in Denmark. Scandinavian Journal of Public Health. https://doi.org/10.1177/14034948251333901
Vancouver
Dudukina E, Brâuner EV, Christiansen CB, Mogensen SH, Hervig ME, Ulsø S, et al. Associations between mRNA COVID-19 vaccination and urticaria: a nationwide registry-based cohort study in Denmark. Scandinavian Journal of Public Health. 2025. doi:10.1177/14034948251333901
BibTeX
@article{Dudukina2025,
author = {Dudukina, Elena and Brâuner, Elvira V and Christiansen, Cæcilie B and Mogensen, Stine H and Hervig, Mona E and Ulsø, Stine and Larsen, Martin Z},
title = {Associations between mRNA COVID-19 vaccination and urticaria: a nationwide registry-based cohort study in Denmark},
journal = {Scandinavian Journal of Public Health},
year = {2025},
doi = {10.1177/14034948251333901}
}
EUVIMED